Trials / Completed
CompletedNCT03994809
International Study of Biofield Therapy
International Cross-sectional Study on the Effectiveness of Biofield Therapy for the Relief of Various Symptoms
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 12,000 (actual)
- Sponsor
- MOA Health Science Foundation · Academic / Other
- Sex
- All
- Age
- 16 Years
- Healthy volunteers
- Accepted
Summary
Participants from 14 different countries received a single session of biofield therapy (Okada Purifying Therapy) lasting 30 minutes or longer from the volunteer practitioners. Before and after the therapy, they reported the severity of physical pain, anxiety/depression, dizziness/palpitation, and overall symptoms. The team compared the effectiveness/safety of biofield therapy between countries and analyzed the factors associated with the outcomes.
Detailed description
Participants aged 16 or older from 14 different countries (Japan, USA, Argentina, Brazil, Chile, Mexico, Peru, Taiwan, Thai, South Korea, Belgium, France, Portugal, and Spain) received a single session of biofield therapy (Okada Purifying Therapy) lasting 30 minutes or longer from the volunteer practitioners in their country of residence. Before and after the intervention, they reported each severity level of physical pain, anxiety/depression, dizziness/palpitation, and overall symptoms. The team compared the improvement/exacerbation rate of a single session of biofield therapy between the countries, and examined the adjusted odds ratio of the variables associated with the changes in each category of symptoms in a real-world setting.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | Okada Purifying Therapy | The practitioner raises his/her hand forward towards the recipient with the palm directed toward the recipient. The practitioner uses his/her hands alternately during the administration of Okada Purifying Therapy. The distance between the palm and the body is usually 1-2 feet, with each session typically lasting 30 to 60 minutes. |
Timeline
- Start date
- 2008-01-01
- Primary completion
- 2010-09-30
- Completion
- 2010-09-30
- First posted
- 2019-06-21
- Last updated
- 2019-06-21
Source: ClinicalTrials.gov record NCT03994809. Inclusion in this directory is not an endorsement.